Tauroselcholic acid

Star0

DB15973InvestigationalSmall molecule

Tauroselcholic acid: Overview.

Formula / weight: C₂₆H₄₅NO₇SSe · 594.68 g/mol (avg)
Also known as: SeHCAT

Resolves to

Compound

UNIIH6630PU5ZJCAS75018-71-2ChEMBLCHEMBL3707263

Structure

InChIKeyJCMLWGQJPSGGEI-HZAMXZRMSA-NSMILES

[H]O[C@@H]1CC[C@@]2(C)[C@@]([H])(C1)C[C@@H](O[H])[C@@]1([H])[C@]3([H])CC[C@]([H])([C@H](C)C[Se]CC(=O)N([H])CCS(=O)(=O)O[H])[C@@]3(C)[C@@H](O[H])C[C@]21[H]

Transporters

Q12908SLC10A2

What you can answer from here — as of September 12, 2026

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Tauroselcholic acid, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account